[18f]nos
Small moleculeexperimentalImaging agent
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 23, 2018 (NCT03721822)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05885594 | Early Phase 1 (Phase 1) | Apr 25, 2023 | University of Pennsylvania |
| NCT04401917 | Early Phase 1 (Phase 1) | Aug 1, 2020 | University of Pennsylvania |
| NCT04274998 | Early Phase 1 (Phase 1) | Mar 1, 2020 | University of Pennsylvania |
| NCT04105634 | Early Phase 1 (Phase 1) | Oct 1, 2019 | University of Pennsylvania |
| NCT04062526 | Early Phase 1 (Phase 1) | Aug 14, 2019 | University of Pennsylvania |
| NCT03721822 | Phase 1 | Oct 23, 2018 | University of Pennsylvania |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pennsylvania | Academic/Hospital | 6 | 6 | 1 | 2018 |
1 organizations
Page 1 / 1